FK778 and tacrolimus prevent the development of obliterative airway disease after heterotopic rat tracheal transplantation

Journal of Heart and Lung Transplantation

Volumn 24, Issue 11, 2005, Pages 1844-1854

  Deuse, Tobias ^a   Schrepfer, Sonja ^a   Koch Nolte, Friedrich ^a   Haddad, Munif ^a   Schwedhelm, Edzard ^a   Böger, Rainer ^a   Schäfer, Hansjörg ^a   Detter, Christian ^a   Reichenspurner, Hermann ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYANO 3 HYDROXY N [4 (TRIFLUOROMETHYL)PHENYL] 6 HEPTYNAMIDE; ALPHA ACTIN; CD4 ANTIGEN; CD8 ANTIGEN; COLLAGEN; INTERLEUKIN 2 RECEPTOR ALPHA; LYMPHOCYTE ANTIGEN; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG TOXICITY; EPITHELIUM; FIBROSIS; GOBLET CELL; GRANULATION TISSUE; GREATER OMENTUM; HETEROTOPIC TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE; MALE; MONONUCLEAR CELL; NONHUMAN; ORGAN TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; QUANTITATIVE ANALYSIS; RAT; RECIPIENT; SMOOTH MUSCLE FIBER; TRACHEA GRAFT; TRACHEA SURGERY; UPPER RESPIRATORY TRACT OBSTRUCTION;

ACTINS; ALKYNES; ANIMALS; BRONCHIOLITIS OBLITERANS; DISEASE MODELS, ANIMAL; GRANULATION TISSUE; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; LYMPHOCYTE ACTIVATION; NITRILES; POSTOPERATIVE COMPLICATIONS; RATS; RATS, INBRED BN; RATS, INBRED LEW; TACROLIMUS; TRACHEA;

EID: 27844594950     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.03.005     Document Type: Article

References (32)

1. S. Sundaresan, E.P. Trulock, T. Mohanakumar, J.D. Cooper, G.A. Patterson Washington University Lung Transplant Group Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation Ann Thorac Surg 60 1995 1341 1346
2. V.G. Valentine, R.C. Robbins, G.J. Berry Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis J Heart Lung Transplant 15 1996 371 383
3. S.A. Yousem, J.A. Dauber, R. Keenan, I.L. Paradis, A. Zeevi, B.P. Griffith Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation 52 1991 306 309
4. I. Paradis, S. Yousem, B. Griffith Airway obstruction and bronchiolitis obliterans after lung transplantation Clin Chest Med 14 1993 751 763
5. M.I. Hertz, J. Jessurun, M.B. King, S.K. Savik, J.J. Murray Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways Am J Pathol 142 1993 1945 1951
6. X.H. Huang, H. Reichenspurner, R. Shorthouse, R.E. Morris Heterotopic tracheal allograft transplantation a new model to study the molecular events causing obliterative airway disease (OAD) in rats J Heart Lung Transplant 14 suppl 1995 49
7. H. Reichenspurner, V. Soni, M. Nitschke Obliterative airway disease after heterotopic tracheal xenotransplantation pathogenesis and prevention using new immunosuppressive agents Transplantation 64 1997 373 383
8. R.E. Morris, X. Huang, C.R. Gregory Studies in experimental models of chronic rejection use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis Transplant Proc 27 1995 2068 2069
9. P.K. Koskinen, E.A. Kallio, R. Krebs, K.B. Lemstrom A dose-dependent inhibitory effect of cyclosporine A on obliterative bronchiolitis of rat tracheal allografts Am J Respir Crit Care Med 155 1997 303 312
10. K.E. Kelly, M.I. Hertz, D.L. Mueller T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas Transplantation 66 1998 764 771
11. A. Boehler, D. Chamberlain, S. Kesten, A.S. Slutsky, M. Liu, S. Keshavjee Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans Transplantation 64 1997 311 317
12. H.T. Silva Jr, R.E. Morris Leflunomide and malononitrilamides Am J Med Sci 313 1997 289 301
13. T. Deuse, S. Schrepfer, H. Reichenspurner Immunosuppression with FK778 and mycophenolate mofetil in a rat cardiac transplantation model Transplantation 76 2003 1627 1629
14. K.K. Bilolo, J. Ouyang, X. Wang Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat Transplantation 75 2003 1881 1887
15. H. Furukawa, S. Todo Evolution of immunosuppression in liver transplantation contribution of cyclosporine Transplant Proc 36 suppl 2 2004 274 284
16. T. Deuse, S. Schrepfer, H. Reichenspurner The interaction between FK778 and tacrolimus in the prevention of rat cardiac allograft rejection is dose dependent Transplantation 77 2004 509 513
17. T. Deuse, S. Schrepfer, H. Schafer FK778 attenuates lymphocyte- endothelium interaction after cardiac transplantation in vivo and in vitro studies Transplantation 78 2004 71 77
18. H. Jiang, X. Yang, R.N. Soriano, T. Fujimura, K. Krishnan, M. Kobayashi Distinct patterns of cytokine gene suppression by the equivalent effective doses of cyclosporine and tacrolimus in rat heart allografts Immunobiology 202 2000 280 292
19. Y. Vanrenterghem, J.P. van Hooff, M. Klinger The effects of FK778 in combination with tacrolimus and steroids a phase II multicenter study in renal transplant patients Transplantation 78 2004 9 14
20. D.O. Taylor, M.L. Barr, B.M. Meiser, S.M. Pham, R.M. Mentzer, A.L. Gass Suggested guidelines for the use of tacrolimus in cardiac transplant recipients J Heart Lung Transplant 20 2001 734 738
21. N.A. Yonan, P. Bishop, A. el-Gamel, I.V. Hutchinson Tracheal allograft transplantation in rats the role of immunosuppressive agents in development of obliterative airway disease Transplant Proc 30 1998 2207 2209
22. A. Dosanjh, B. Wan, T. Ikonen, K. Boeke, R.E. Morris Airway goblet cells and respiratory epithelial injury in an animal model of obliterative airways disease (OAD) Am J Transplant 1 2001 321 324
23. H.S. Alho, U.S. Salminen, P.K. Maasilta, P. Paakko, A.L. Harjula Epithelial apoptosis in experimental obliterative airway disease after lung transplantation J Heart Lung Transplant 22 2003 1014 1022
24. P.M. Taylor, M.L. Rose, M.H. Yacoub Expression of MHC antigens in normal human lungs and transplanted lungs with obliterative bronchiolitis Transplantation 48 1989 506 510
25. B.F. Adams, T. Brazelton, G.J. Berry, R.E. Morris The role of respiratory epithelium in a rat model of obliterative airway disease Transplantation 69 2000 661 664
26. M.B. King, A.C. Pedtke, H.L. Levrey-Hadden, M.I. Hertz Obliterative airway disease progresses in heterotopic airway allografts without persistent alloimmune stimulus Transplantation 74 2002 557 562
27. J.L. Jordan, C.L. Hurley, T.D. Lee, G.M. Hirsch Recipient cells form the proliferative lesion in the rat heterotopic tracheal allograft model of obliterative airway disease J Heart Lung Transplant 22 2003 357 360
28. R.V. Nair, W. Cao, R.E. Morris Inhibition of smooth muscle cell proliferation in vitro by leflunomide, a new immunosuppressant, is antagonized by uridine Immunol Lett 47 1995 171 174
29. A. Lun, M.Y. Cho, C. Muller Diagnostic value of peripheral blood T-cell activation and soluble IL-2 receptor for acute rejection in liver transplantation Clin Chim Acta 320 2002 69 78
30. T. Birsan, C. Dambrin, J. Klupp In vivo pharmacokinetic and pharmacodynamic evaluation of the malononitrilamide FK778 in non-human primates Transplant Int 16 2003 354 360
31. H.T. Silva, W. Cao, R. Shorthouse, R.E. Morris Mechanism of action of leflunomide in vivo uridine administration reverses its inhibition of lymphocyte proliferation Transplant Proc 28 1996 3082 3084
32. R. Weimer, A. Melk, V. Daniel, S. Friemann, W. Padberg, G. Opelz Switch from cyclosporine A to tacrolimus in renal transplant recipients impact on Th1, Th2, and monokine responses Hum Immunol 61 2000 884 897